Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer
Published Online: 2023-01-?
Journal: Therapeutic Advances in Medical OncologyLoading...
Authors: Aditya Bardia•Agnes Lteif•Arunava Chakravartty•Binghe Xu•Carlos H. Barrios•Chiun-Sheng Huang•Daniil Stroyakovskiy•Denise A. Yardley•Dennis J. Slamon•Frances Visco•Gabriel N. Hortobagyi•John Crown•Juan Pablo Zarate•Karen Afenjar•Michael Untch•Miguel Martín•Peter A. Fasching•Rebecca L. Moroose•Rodrigo Fresco•Sara Hurvitz•Seock-Ah Im•Sherene Loi•Stephen Chia•Tetiana Taran•Valerie Bee-Munteanu
